Arrowstreet Capital, Limited Partnership Neurocrine Biosciences Inc Transaction History

Arrowstreet Capital, Limited Partnership

$108 Billion
Q1 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 30,763 shares of NBIX stock, worth $4.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,763

Holding current value

$4.24 Million

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $4.01 Million - $4.42 Million	30,763 New	30,763 $4.24 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $433,504 - $507,780	-4,842 Reduced 6.32%	71,770 $6.77 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $1.17 Million - $1.52 Million	12,386 Added 19.29%	76,612 $7.76 Million
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $15.3 Million - $18.2 Million	-143,124 Reduced 69.03%	64,226 $7.67 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $9.24 Million - $10.8 Million	100,361 Added 93.8%	207,350 $22 Million

Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $811,407 - $1.07 Million	10,706 Added 11.12%	106,989 $10.4 Million
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $1.17 Million - $1.53 Million	-16,099 Reduced 14.33%	96,283 $9.03 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $8.95 Million - $11.9 Million	112,382 New	112,382 $9.57 Million
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $1.12 Million - $1.4 Million	-12,900 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $1.24 Million - $1.74 Million	12,900 New	12,900 $1.24 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $1.26 Million - $2.29 Million	-18,400 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $1.82 Million - $2.32 Million	18,400 New	18,400 $2.26 Million
Q2 2018 Aug 14, 2018	SELL	$75.3 - $105.99 $1.4 Million - $1.97 Million	-18,600 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$75.88 - $92.43 $1.41 Million - $1.72 Million	18,600 New	18,600 $1.54 Million

Others Institutions Holding NBIX

# of Institutions

628

Shares Held

94.4M

Call Options Held

505K

Put Options Held

343K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Neurocrine Biosciences Inc Transaction History